Abstract
Vascular permeability regulated by the vascular endothelial growth factor (VEGF) through endothelial-barrier junctions is essential for inflammation. Mechanisms regulating vascular permeability remain elusive. Although ‘Akt’ and ‘Src’ have been implicated in the endothelial-barrier regulation, it is puzzling how both agents that protect and disrupt the endothelial-barrier activate these kinases to reciprocally regulate vascular permeability. To delineate the role of Akt1 in endothelial-barrier regulation, we created endothelial-specific, tamoxifen-inducible Akt1 knockout mice and stable ShRNA-mediated Akt1 knockdown in human microvascular endothelial cells. Akt1 loss leads to decreased basal and angiopoietin1-induced endothelial-barrier resistance, and enhanced VEGF-induced endothelial-barrier breakdown. Endothelial Akt1 deficiency resulted in enhanced VEGF-induced vascular leakage in mice ears, which was rescued upon re-expression with Adeno-myrAkt1. Furthermore, co-treatment with angiopoietin1 reversed VEGF-induced vascular leakage in an Akt1-dependent manner. Mechanistically, our study revealed that while VEGF-induced short-term vascular permeability is independent of Akt1, its recovery is reliant on Akt1 and FoxO-mediated claudin expression. Pharmacological inhibition of FoxO transcription factors rescued the defective endothelial barrier due to Akt1 deficiency. Here we provide novel insights on the endothelial-barrier protective role of VEGF in the long term and the importance of Akt1-FoxO signaling on tight-junction stabilization and prevention of vascular leakage through claudin expression.
Similar content being viewed by others
Abbreviations
- VEGF:
-
Vascular endothelial growth factor
- Ang-1:
-
Angiopoietin-1
- VECad-Cre-Ak1:
-
Vascular endothelial cadherin-cre recombinase-Akt1 knockdown
- HMEC:
-
Human microvascular endothelial cells
- FoxO:
-
Forkhead box protein O
- ECIS:
-
Electric cell-substrate impedance sensing
- WT:
-
Wild type
- GFP:
-
Green fluorescent protein
- eNOS:
-
Endothelial nitric oxide synthase
- AJ:
-
Adherens junction
- TJ:
-
Tight junction
- Zo:
-
Zona occludens
References
Nagy JA, Dvorak AM, Dvorak HF (2012) Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harbor Perspect Med 2:a006544
Goddard LM, Iruela-Arispe ML (2013) Cellular and molecular regulation of vascular permeability. Thromb Haemost 109:407–415
Chen J, Somanath PR, Razorenova O et al (2005) Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat Med 11:1188–1196
Ha CH, Bennett AM, Jin ZG (2008) A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J Biol Chem 283:7261–7270
Daly C, Wong V, Burova E et al (2004) Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). Genes Dev 18:1060–1071
Gavard J, Patel V, Gutkind JS (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14:25–36
Weis SM (2008) Vascular permeability in cardiovascular disease and cancer. Curr Opin Hematol 15:243–249
Augustin HG, Koh GY, Thurston G et al (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10:165–177
Murakami M, Nguyen LT, Zhuang ZW et al (2008) The FGF system has a key role in regulating vascular integrity. J Clin Invest 118:3355–3366
Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:1223–1234
Esser S, Lampugnani MG, Corada M et al (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111(Pt 13):1853–1865
Jones CA, London NR, Chen H et al (2008) Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med 14:448–453
Ngok SP, Geyer R, Liu M et al (2012) VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx. J Cell Biol 199:1103–1115
Somanath PR, Kandel ES, Hay N et al (2007) Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem 282:22964–22976
De Palma C, Meacci E, Perrotta C et al (2006) Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol 26:99–105
Singleton PA, Chatchavalvanich S, Fu P et al (2009) Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 104:978–986
Ackah E, Yu J, Zoellner S et al (2005) Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Investig 115:2119–2127
Xue Q, Hopkins B, Perruzzi C et al (2008) Palomid 529, a novel small-molecule drug, is a TORC1/TORC2 inhibitor that reduces tumor growth, tumor angiogenesis, and vascular permeability. Cancer Res 68:9551–9557
Somanath PR, Razorenova OV, Chen J et al (2006) Akt1 in endothelial cell and angiogenesis. Cell Cycle 5:512–518
Mukai Y, Rikitake Y, Shiojima I et al (2006) Decreased vascular lesion formation in mice with inducible endothelial-specific expression of protein kinase Akt. J Clin Invest 116:334–343
Taddei A, Giampietro C, Conti A et al (2008) Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10:923–934
Ashida N, Senbanerjee S, Kodama S et al (2011) IKKbeta regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways. Nat Commun 2:318
Qi X, Okamoto Y, Murakawa T et al (2010) Sustained delivery of sphingosine-1-phosphate using poly(lactic-co-glycolic acid)-based microparticles stimulates Akt/ERK-eNOS mediated angiogenesis and vascular maturation restoring blood flow in ischemic limbs of mice. Eur J Pharmacol 634:121–131
Kogata N, Arai Y, Pearson JT et al (2006) Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization. Circ Res 98:897–904
Gao F, Al-Azayzih A, Somanath PR (2015) Discrete functions of GSK3alpha and GSK3beta isoforms in prostate tumor growth and micrometastasis. Oncotarget 6:5947–5962
Goc A, Al-Azayzih A, Abdalla M et al (2013) P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor beta expression and enhanced matrix metalloproteinase 9 secretion. J Biol Chem 288:3025–3035
Al-Azayzih A, Gao F, Somanath PR (2015) P21 activated kinase-1 mediates transforming growth factor beta1-induced prostate cancer cell epithelial to mesenchymal transition. Biochim Biophys Acta 1853:1229–1239
Abdalla M, Goc A, Segar L et al (2013) Akt1 mediates alpha-smooth muscle actin expression and myofibroblast differentiation via myocardin and serum response factor. J Biol Chem 288:33483–33493
Gavard J, Gutkind JS (2008) VE-cadherin and claudin-5: it takes two to tango. Nat Cell Biol 10:883–885
Azzi S, Hebda JK, Gavard J (2013) Vascular permeability and drug delivery in cancers. Front Oncol 3:211
Ruan GX, Kazlauskas A (2012) Axl is essential for VEGF-A-dependent activation of PI3 K/Akt. EMBO J 31:1692–1703
Predescu D, Predescu S, Shimizu J et al (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 289:L371–L381
Potente M, Urbich C, Sasaki K et al (2005) Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 115:2382–2392
O’Neill BT, Abel ED (2005) Akt1 in the cardiovascular system: friend or foe? J Clin Invest 115:2059–2064
Oellerich MF, Potente M (2012) FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res 110:1238–1251
Krug SM, Gunzel D, Conrad MP et al (2012) Claudin-17 forms tight junction channels with distinct anion selectivity. Cell Mol Life Sci 69:2765–2778
Acknowledgments
Funds were provided by the National Institutes of Health Grant (R01HL103952) to PRS. This material is the result of work supported with resources and the use of facilities at the Charlie Norwood VAMC, Augusta, GA. The funders had no role in the study design, data collection, analysis and decision to publish. Preparation of the manuscript and the contents do not represent the views of the Department of Veterans Affairs or the United States Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that there are no financial or conflicts of interests exist.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gao, F., Artham, S., Sabbineni, H. et al. Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover. Cell. Mol. Life Sci. 73, 3917–3933 (2016). https://doi.org/10.1007/s00018-016-2232-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-016-2232-z